These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1935442)

  • 21. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram.
    Palmowski AM; Sutter EE; Bearse MA; Fung W
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2586-96. PubMed ID: 9375578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy?
    Holmes-Walker DJ; Mitchell P; Boyages SC
    Diabet Med; 1998 Nov; 15(11):946-52. PubMed ID: 9827849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy.
    Corduneanu A; Chişca V; Ciobanu N; Groppa S
    Rom J Ophthalmol; 2019; 63(4):367-371. PubMed ID: 31915735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual evoked potentials in infants of diabetic mothers: relations to clinical and metabolic status during pregnancy and delivery.
    Brinciotti M; Matricardi M; Colatrella A; Torcia F; Fallucca F; Napoli A
    Clin Neurophysiol; 2009 Mar; 120(3):563-8. PubMed ID: 19181572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual evoked potentials for reversals of red-green gratings with different chromatic contrasts: asymmetries with respect to isoluminance.
    Rudvin I
    Vis Neurosci; 2005; 22(6):749-58. PubMed ID: 16469185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photopic electroretinogram implicit time in diabetic retinopathy.
    Satoh S; Iijima H; Imai M; Abe K; Shibuya T
    Jpn J Ophthalmol; 1994; 38(2):178-84. PubMed ID: 7967210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pattern electroretinography and pattern visual evoked potentials in maculopathy: a comparison with sensory tests].
    Niermann F; Lorenz R; Heider W
    Fortschr Ophthalmol; 1989; 86(1):54-8. PubMed ID: 2722101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroretinogram changes after fluorescein injection: a new method to evaluate blood-retinal barrier dysfunction.
    Tamai M; Mizuno K
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):272-6. PubMed ID: 7461931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic value of electrophysiologic studies in diabetics in our experience].
    Palacz O; Czepita D; Lubiński W; Wieliczko W; Czekalski S
    Klin Oczna; 1989; 91(7-9):191-3. PubMed ID: 2638441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The rhythmic ERG in the diagnosis of diabetic retinopathy in cataract patients].
    Tsapenko IV; Zueva MV; Bessmertnyĭ AM
    Oftalmol Zh; 1990; (8):467-70. PubMed ID: 2095471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Using deltalicin for the treatment of patients with diabetic retinopathy].
    Kresiun NV; Godlevskiĭ LS
    Eksp Klin Farmakol; 2014; 77(12):22-5. PubMed ID: 25739189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvment of the visual evoked potentials in type I insulin-dependent diabetes.
    Ponte F; Giuffrè G; Anastasi M; Lauricella M
    Metab Pediatr Syst Ophthalmol (1985); 1986; 9(2-4):77-80. PubMed ID: 3452012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The objective measure of color vision in primary open angle glaucoma.
    Zehong W; Lezheng W; De-zheng W; Jiongji L
    Yan Ke Xue Bao; 1997 Sep; 13(3):128-32. PubMed ID: 11326863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative retinopathy: value of the oscillatory potentials.
    Lazzarino LG; Nicolai A
    Electromyogr Clin Neurophysiol; 1992 Sep; 32(9):477-80. PubMed ID: 1396301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [First flash and second flash ERPs (early receptor potentials) in diabetic retinopathy (author's transl)].
    Tamai A; Ueno H; Noda K; Kishi S; Iyota K
    Nippon Ganka Gakkai Zasshi; 1982; 86(5):484-8. PubMed ID: 7113837
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control.
    Ziegler O; Guerci B; Algan M; Lonchamp P; Weber M; Drouin P
    Diabetes Care; 1994 Oct; 17(10):1141-7. PubMed ID: 7821133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wavelength-dependent abnormalities of pattern evoked cortical responses in young diabetics.
    Schauseil-Zipf U; Puyn U; Schulte K; Sickel W
    Dev Ophthalmol; 1984; 9():94-101. PubMed ID: 6526116
    [No Abstract]   [Full Text] [Related]  

  • 38. Visual Evoked Potentials for the Detection of Diabetic Retinal Neuropathy.
    Miura G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the metabolic control on latency values of visual evoked potentials (VEP) in patients with diabetes mellitus type 1.
    Matanovic D; Popovic S; Parapid B; Petronic I; Cirovic D; Nikolic D
    Arch Ital Biol; 2012 Dec; 150(4):251-8. PubMed ID: 23479458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cone sensitivity measurements in diabetic retinopathy].
    Toyoguchi A; Kudo H; Rokugo T; Usui M
    Nippon Ganka Gakkai Zasshi; 1998 Feb; 102(2):117-22. PubMed ID: 9513358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.